{
    "medicine_id": "e5294fb316c669e9a35881581128a204031cb736",
    "platform_id": "DB06752",
    "metadata": {
        "name": "Chymodiactin Injection 4 Nkat Units 2ml Powder for solution",
        "composition": "Chymopapain",
        "clinical_particulars": {
            "therapeutic_indications": "Chymopapain is indicated for the development of chemonucleolysis which is used for the digestion of the nucleus pulposus in patients with disc herniation confirmed by myelography A32687 A disc herniation occurs when the outer portion of the spinal disc breaks down and the inner portion nucleus pulposus leaks out pressing surrounding nerves and leading to irradiating pain L2496 The chemonucleolysis is a non surgical treatment that involves the injection of an enzyme to dissolve the nucleus pulposus L2482",
            "contraindications": {
                "disease": "The median lethal dose of chymopapain in mice is registered to be 82 mg kg and the toxicity mechanism was caused by hemorrhage due to the destruction of the cement substance in the blood vessels When administered in an overdosage chymopapain was able to nearly completely dissolve the nucleus pulposus and cause the disruption of the annulus fibrosus A32706",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "The first studies showed that after intradiscal injection of chymopapain the effect involved the removal of the nucleus pulposus leaving the annulus intact L2482 The clinical reports indicated a spontaneous remission of symptoms after the administration of chymopapain It is also highly documented an increased urinary excretion of glycosaminoglycans A32701",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}